MicroPort NeuroScientific Grants 550,000 Share Options to Key Employees

MicroPort NeuroTech Limited ( (HK:2172) ) has issued an announcement.

MicroPort NeuroScientific Corporation has granted 550,000 share options to two group employees under its share scheme adopted in July 2023, with an exercise price of HK$10.97 per share and a 10-year validity period. The options will vest in equal 20% tranches over five years without additional performance targets, but are subject to clawback provisions including lapse upon cessation of employment and cancellation at the board’s discretion.

The remuneration committee considers the grants aligned with the scheme’s aim of incentivizing staff and promoting the Group’s business development, with allocation based on the grantees’ work performance and potential. None of the grantees are directors, chief executives, substantial shareholders, related entity participants, or service providers, and the company confirms no financial assistance was provided for share purchases and that individual limits under listing rules have not been breached.

The most recent analyst rating on (HK:2172) stock is a Buy with a HK$13.00 price target. To see the full list of analyst forecasts on MicroPort NeuroTech Limited stock, see the HK:2172 Stock Forecast page.

More about MicroPort NeuroTech Limited

MicroPort NeuroScientific Corporation is a Cayman Islands-incorporated medical technology company listed in Hong Kong that operates through its subsidiaries as part of the MicroPort NeuroTech group. The Group focuses on neuro-related medical devices and technologies, and uses equity-based incentive schemes to retain and motivate key employees in support of its long-term business development.

Average Trading Volume: 6,434,361

Technical Sentiment Signal: Sell

Current Market Cap: HK$6.15B

Find detailed analytics on 2172 stock on TipRanks’ Stock Analysis page.